(S)-3,3-DIFLUOROCYCLOPENTANAMINE HCL, 95.0%, 100mg

tert-Butyl 4-(2-(ethoxycarbonyl)benzofuran-5-yl)piperazine-1-carboxylate, 95.0%, 100g

3-(Triphenylphosphoranylidene)dihydrofuran-2,5-dione, 97%, 5g

2,2-Dimethyl-N-[2-(5-methyl-[1,2,4]oxadiazol-3-yl)-ethyl]-propionamide, 95.0%, 1g

3,4-Dichloro-5-(chlorosulfonyl)benzoic acid, 95+%, 100mg

1-(tetrahydro-2H-pyran-4-yl)-4-piperidinamine dihydrochloride, 95.0%, 5g

1-(3-methoxy-4-nitrophenyl)piperidin-4-one, 97%, 5g

Vinyl 2-Ethylhexanoate (stabilized with MEHQ)>98.0%(GC)500mL

(7S,8aS)-7-aminohexahydropyrrolo[1,2-a]pyrazine-1,4-dione hydrochloride, 95.0%, 250mg

Methyl 7-methyl-1H-indole-3-carboxylate, 95.0%, 10g

5-(2-Methoxyphenyl)-1,3,4-thiadiazol-2-amine, 95.0%, 10g

Methyl 2-amino-5-bromo-3-methoxybenzoate, 98%, 1g

3-(Hydroxymethyl)-4-methoxyphenylboronic Acid (contains varying amounts of Anhydride)1g